Frontiers in Cardiovascular Medicine

JANUARY 28, 2024

Introduction A high recurrence rate of atrial fibrillation was monitored after catheter ablation for persistent atrial fibrillation. The results will evaluate sacubitril/valsartan as a novel treatment for improving prognosis and a complement to conventional drug therapy.

Atrial Fibrillation 64

Atrial Fibrillation Heart Failure Ablation Electrocardiogram 64

Medical Xpress - Cardiology

SEPTEMBER 2, 2024

2 at this year's ESC Congress 2024.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Tachycardia 40

American College of Cardiology

FEBRUARY 19, 2025

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heart failure (HF) hospitalization and atrial fibrillation (AFib) recurrence.

AFIB 67

AFIB Ablation Atrial Fibrillation Outcomes 67

HeartRhythm

APRIL 30, 2024

Catheter Ablation for Atrial Fibrillation (AFib) in heart failure is now a class I indication for patients with heart failure. Evidence supports the relationship between obesity and the incidence and recurrence of Afib.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Obesity Ablation 40

HeartRhythm

OCTOBER 21, 2024

Clinical outcomes among patients with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) treated with catheter ablation (CA) versus antiarrhythmic therapy (AAT) are not well-known.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

DAIC

MARCH 5, 2024

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation 5. Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device 6. Machine Learning Informs a New Tool to Guide Treatment for Acute Decompensated Heart Failure 8.

Heart Failure 111

Heart Failure Atrial Fibrillation Interventional Cardiology Heart Valves 111

Circulation

OCTOBER 13, 2024

Circulation, Volume 150, Issue 16 , Page 1220-1222, October 15, 2024.

Atrial Fibrillation 81

Atrial Fibrillation Heart Failure Ablation Circulation 81

HeartRhythm

MAY 2, 2024

The optimal treatment for atrial fibrillation (AF) in patients with heart failure with reduced ejection fraction (HFrEF) remains unsettled.

Atrial Fibrillation 45

Atrial Fibrillation Heart Failure Ablation 45

DAIC

JUNE 4, 2024

American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged 3.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

HeartRhythm

SEPTEMBER 25, 2024

Atrial fibrillation (AF) is a common reversible cause of worsening left ventricular ejection fraction (LVEF) in patients with heart failure. Guidelines propose a class 1 recommendation for AF catheter ablation (CA) in patients with heart failure with reduced ejection fraction1,2.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). Catheter ablation of AF has been proven to be an effective therapeutic option for AF management in HF, particularly in heart failure with reduced ejection fraction (HFrEF) [2, 3].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Journal of Cardiovascular Electrophysiology

AUGUST 7, 2023

Abstract A vast amount of now well-established clinical and epidemiological data indicates a close, interdependent, and symbiotic association between atrial fibrillation (AF) and heart failure (HF). whether ablation is mandatory or pointless in patients who have HF).

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

The efficacy of catheter ablation as a treatment approach for patients with concurrent atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) has been inadequately investigated.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) for atrial fibrillation (AF) and heart failure with reduced ejection fraction <40% (HFrEF) is associated with improved outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Quality of Life 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Overview of the study population and effects observed after catheter ablation for atrial fibrillation. Herein we describe the effects of catheter ablation on AF burden, arrhythmia recurrences, and ventricular function in end-stage HF. to 39.18.3% ( p <0.001) following ablation. PVI, pulmonary vein isolation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

HeartRhythm

APRIL 14, 2024

The benefit of catheter ablation in patients with atrial fibrillation (AF) for patients with heart failure with preserved ejection fraction (HFpEF) remains uncertain.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

AUGUST 18, 2024

The impact of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial fibrillation (AF) recurrence outcomes and adverse cardiovascular outcomes in heart failure (HF) patients after AF ablation is unknown.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HCPLive

APRIL 26, 2024

A meta-analysis of 12 trials suggests catheter ablation for atrial fibrillation reduces heart failure events in HFrEF patients but not in HFpEF.

Ablation 59

Ablation Atrial Fibrillation AFIB Heart Failure 59

DAIC

JANUARY 5, 2024

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation 3. Atrial Fibrillation Market Reaches $20.92B, According to New Report 9. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study

Atrial Fibrillation 105

Atrial Fibrillation Aortic valve Cardiothoracic Interventional Cardiology 105

HeartRhythm

APRIL 30, 2024

Studies have suggested that early atrial fibrillation (AF) ablation is associated with improved outcomes. However, it is unknown whether these patterns hold for persistent AF among patients with heart failure with preserved ejection fraction (HFpEF). The majority of these studies evaluated paroxysmal AF cases.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

MAY 2, 2024

The authors claim that their score identifies heart failure (HF) patients who benefit the most from atrial fibrillation (AF) ablation. in favour of ablation in the “high-risk group” and 0.41 However, the crude hazard ratio (HR) for the primary endpoint was 0.32 in the “low-risk group”.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

Previous studies have demonstrated significant morbidity and mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), particularly with accompanying atrial fibrillation (AF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 30, 2024

Left atrial and pulmonary artery pressure (PAP) elevation can reflect severity and dynamic status of heart failure (HF) in HF with preserved ejection fraction (pEF). Atrial fibrillation (AF) worsens HFpEF progression and pump failure, but catheter ablation can restore rhythm control in this population.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Open Heart

AUGUST 4, 2023

Objective This study aims to leverage natural language processing (NLP) and machine learning clustering analyses to (1) identify co-occurring symptoms of patients undergoing catheter ablation for atrial fibrillation (AF) and (2) describe clinical and sociodemographic correlates of symptom clusters. female, 58% white).

Atrial Fibrillation 52

Atrial Fibrillation Ablation Chest Pain Document 52

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) of atrial fibrillation (AF) has been proved to benefit patient with symptomatic AF and heart failure. However, the data on neurological outcomes including cerebrovascular disease (CVA) and dementia remain a controversy.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Cerebrovascular Disease Dementia 40

HeartRhythm

MAY 2, 2024

To fully understand the predictive value of the CASTLE-HTx risk-score in relation to the benefits of catheter ablation in patients with end-stage heart failure (HF) and atrial fibrillation (AF), it is essential to distinguish between absolute and relative risk reduction. 100 patient years)1.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation 40

American College of Cardiology

APRIL 24, 2024

The PRO portion of the currently featured PRO/CON debate between Dr. Brian Olshansky and Dr. John Mandrola presents a significant conundrum within the fields of electrophysiology and geriatric cardiology.

Atrial Fibrillation 59

Atrial Fibrillation Heart Failure Electrophysiology Ablation 59

HeartRhythm

APRIL 9, 2024

Atrial fibrillation (AF) and heart failure (HF) frequently coexist. Prediction of left ventricular ejection fraction (LVEF) recovery after catheter ablation (CA) for AF remains difficult.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Biomarkers Heart Failure 40

HeartRhythm

APRIL 30, 2024

Catheter ablation(CA) is a class 1 indication in patients with atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF). It is unclear whether complications differ in patients with HFrEF vs normal left ventricular ejection fraction(LVEF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Outcomes 40

HeartRhythm

APRIL 30, 2024

Catheter ablation (CA) has become a cornerstone in the management of patients with comorbid atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF). Multiple trials have demonstrated the efficacy of CA with respect to symptom improvement and quality of life in AF patients with HFrEF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Quality of Life Heart Failure 40

HeartRhythm

APRIL 30, 2024

A number of studies have examined the impact of atrial fibrillation (AF) ablation on outcomes in heart failure (HF) with reduced ejection (HFrEF) patients. In contrast, data from HF with preserved ejection fraction (HFpEF) patients is limited to small outcome studies and less robust meta-analyses.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Ablation Outcomes 40

American College of Cardiology

MAY 20, 2024

Research covered topics such as outcomes for pediatric subcutaneous ICD implantation; procedural success rates and risk factors associated with catheter ablation for atrial tachyarrhythmias; comparing echocardiographic guidance during left atrial appendage occlusion (LAAO); and atrial fibrillation (AFib) ablation in patients with heart failure with (..)

Heart Rhythm 51

Heart Rhythm Pediatrics Ablation Atrial Fibrillation 51

HeartRhythm

SEPTEMBER 25, 2024

The HFA–PEFF score comprising echocardiographic and laboratory data is designed to diagnose heart failure with preserved ejection fraction and holds prognostic value in patients who underwent catheter ablation for atrial fibrillation (AF).

Preserved Ejection Fraction 40

Preserved Ejection Fraction Laboratory Atrial Fibrillation Ablation 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2025

ABSTRACT Background Atrial fibrillation (AF) recurrence remains a significant challenge in heart failure with reduced ejection fraction (HFrEF) patients undergoing cryoballoon ablation (CBA). Secondary endpoints included all-cause mortality and heart failure (HF)-related hospitalizations.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Ablation Outcomes 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Abstract Background Heart failure (HF) with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are associated with high morbidity and mortality. However, it remains unclear whether SRM after a repeat CA for recurrent AF has the same effect as SRM after the initial CA in patients with AF and HFpEF.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

HeartRhythm

APRIL 30, 2024

The presence of atrial fibrillation (AF) seems to attenuate the response to cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) in patients with heart failure. 2023 HRS guidelines recommend CRT in patients with sinus rhythm (grade 1 recommendation).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure 40

HeartRhythm

APRIL 30, 2024

Most clinical trials have suggested that strictly controlling resting heart rate (RHR) lower than 110 beats per minute (bpm) even less than 100 bpm is beneficial. However, the degree to which rate control prior to catheter ablation influence is unclear especially in AF patients with heart failure (HF).

Heart Failure 40

Heart Failure Ablation Atrial Fibrillation 40